This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Stocks Climb as Summers Withdrawal Bolsters Stimulus Outlook; Apple Falls

NEW YORK (TheStreet) -- U.S. stocks gained Monday as investors bet on an extension of the Federal Reserve's stimulus program and a smooth leadership transition at the central bank as former U.S. Treasury Secretary Larry Summers withdrew his name from consideration as the next Fed chairman.

Summers, President Obama's apparent favorite to succeed Chairman Ben Bernanke, reportedly removed himself from the running following unusually strong political opposition to his candidacy from Democrats, all but assuring the ascension of current vice-chair and low interest-rate advocate Janet Yellen to run the bank beginning in February.

Markets were further bolstered by Chrysler's plan to file documents this week to hold an initial public offering . Respite from Syria anxieties was also seen as a positive as the U.S. and Russia negotiated a proposal to remove or destroy the Middle Eastern nation's chemical weapons by the middle of next year, delaying airstrikes indefinitely.

The S&P 500 gained 0.57% to 1,697.60. The benchmark index began the session up 18.36% year to date. The Dow Jones Industrial Average added 0.77% to 15,494.78. The Nasdaq dropped 0.12% to 3,717.85.

The Nasdaq's decline came after Wall Street punished Apple (AAPL) for the fourth of the past five trading sessions, almost a week after investors shrugged at the new iPhone 5C and iPhone 5S. Shares dropped 3.2% to $450.12 Monday as the stock won the inauspicious distinction of the day's worst performer on the S&P 500.

Conversely, Allegheny Technologies (ATI) was the biggest gainer on the S&P, jumping 8.1% to $30.95 after the metals producer said it will sell its tungsten materials business to Kennametal (KMT) for $605 million. Kennametal increased 0.9% to $46.39.

Bristol-Myers Squibb (BMY) tacked on 3.6% to $45.14 after analysts at JPMorgan upgraded the pharmaceutical stock to "overweight" from "neutral," lifting its price target to $52 from $50 due to catalysts including the company's immunotherapy platform.

Ahead of the open, the New York Federal Reserve's Empire State manufacturing index showed a smaller-than-expected increase to 6.29 for September from 8.24 in August; an increase to 9.2 was expected, according to a Thomson Reuters poll of economists. It was the lowest level since May but remained in expansionary territory for the fourth consecutive month.

The Federal Reserve said that industrial production rose by an as expected 0.4% in August after being flat in July and that capacity utilization increased to an as predicted 77.8% from 77.6%.

President Obama on Wednesday marked the 5-year anniversary of Lehman Brothers' bankruptcy by listing the various reforms his administration has implemented since the crash, but reminded Americans that the economy is not where it needs to be.

The benchmark 10-year Treasury was lifting by 2/32, diluting the yield to 2.880%.

-- Written by Andrea Tse and Joe Deaux in New York

>To contact the writer of this article, click here: Andrea Tse.>

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,979.13 +59.54 0.35%
S&P 500 1,986.51 +4.91 0.25%
NASDAQ 4,526.4820 -1.0320 -0.02%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs